Company Filing History:
2 out of 29 
2 out of 28 Years Active: 2018-2019
Title: Innovations by Hong-Hul Lin in Ocular Pharmaceuticals
Introduction
Hong-Hul Lin is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions aimed at reducing complications associated with ocular steroids. With a total of 2 patents, his work has the potential to impact the treatment of various ophthalmic diseases.
Latest Patents
Hong-Hul Lin's latest patents focus on pharmaceutical compositions designed to mitigate the side effects of ocular steroids. The inventions involve a combination of a lipid cake mixture containing one or more phospholipids, with or without cholesterol, and a steroid solution comprising an ocular steroid or its derivatives. The formulations are designed to contain a specific amount of phospholipid, ranging from about 0.1 umol to less than about 2.5 umol per 50 µl of the pharmaceutical composition. These compositions are preferably administered via the ocular route to effectively treat ophthalmic diseases while minimizing adverse effects.
Career Highlights
Throughout his career, Hong-Hul Lin has worked with prominent companies in the biopharmaceutical sector. Notable among these are Tlc Biopharmaceuticals, Inc. and Taiwan Liposome Company, Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Hong-Hul Lin has collaborated with several professionals in his field, including Keelung Hong and Luke S S Guo. These collaborations have likely enriched his research and development efforts, leading to advancements in ocular pharmaceuticals.
Conclusion
Hong-Hul Lin's contributions to the field of ocular pharmaceuticals demonstrate his commitment to innovation and improving patient outcomes. His patents reflect a significant step forward in addressing the challenges associated with ocular steroid treatments.